MDS SOHO 2026 Archives - SOHO Insider

Skip to content

Fibrotic low-risk MDS associated with elevated IL-1β and reduced IL-5
Dr. Valeria Santini gives overview of SOHO 2026 MDS session
Drs. Nastoupil and Garcia-Manero discuss Friday’s plenary session at SOHO 2026
Prophylactic tocilizumab can reduce CRS severity during bispecific step-up dosing
Study supports bispecifics as effective post-CAR-T strategy in relapsed/refractory MM

Insider Reader Survey

Join SOHO

Follow Us :

Insider Podcast
Society Updates
Resources
Hem/Onc Library
- Cellular Therapy
- Leukemia
  - ALL
  - AML
  - CLL
  - CML
- Lymphoma
  - ABCL
  - IBCL
  - MCL
  - TCL
- MDS
- MPN
- Multiple Myeloma
Community Oncology
- Past Sessions
Meeting News
Multimedia
- Roundtable Discussions
- Video Interviews
Subscribe

About Us

The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.

Join SOHO

Categories

SOHO 2026 Friday plenary features NIH scientist and aplastic anemia expert Dr. Neal S. Young

Cellular Therapy

SOHO 2026 Friday plenary features NIH scientist and aplastic anemia expert Dr. Neal S. Young

Leukemia

SOHO 2026 Friday plenary features NIH scientist and aplastic anemia expert Dr. Neal S. Young

Lymphoma

SOHO 2026 Friday plenary features NIH scientist and aplastic anemia expert Dr. Neal S. Young

Multiple Myeloma

SOHO 2026 Friday plenary features NIH scientist and aplastic anemia expert Dr. Neal S. Young

Myelodysplastic Syndromes

SOHO 2026 Friday plenary features NIH scientist and aplastic anemia expert Dr. Neal S. Young

Myeloproliferative Neoplasms

Contact Info

[email protected] 1.281.364.7387

Follow Us

September 13, 2026

Insider Podcast
Society Updates
Resources
Hem/Onc Library
- Cellular Therapy
- Leukemia
  - ALL
  - AML
  - CLL
  - CML
- Lymphoma
  - ABCL
  - IBCL
  - MCL
  - TCL
- MDS
- MPN
- Multiple Myeloma
Community Oncology
- Past Sessions
Meeting News
Multimedia
- Roundtable Discussions
- Video Interviews
Subscribe

SOHO Insider Hem/Onc Library Meetings / Conferences SOHO 2026 MDS News

MDS News

News and highlights on MDS from the 14th Annual Meeting of SOHO in Houston.

MDS News SOHO 2026 Trending now Meetings / Conferences News

SOHO 2026 Friday plenary features NIH scientist and aplastic anemia expert Dr. Neal S. Young

by Leah Sherwood
September 10, 2026
0 Comments

MDS News SOHO 2026 Trending now Meetings / Conferences News

Alan List, MD, to receive SOHO Freireich Pioneer Award, deliver Wednesday plenary on lower-risk MDS

by Rami Komrokji, MD
September 8, 2026
0 Comments

MDS News SOHO 2026 Myelodysplastic Syndromes

Post-FDA approval of imetelstat for MDS, several treatment implementation gaps remain

by Kerri Fitzgerald
September 6, 2026
0 Comments

MDS News SOHO 2026 News

Defining the next steps in myelodysplastic syndromes

by Guillermo García-Manero, MD
September 6, 2026
0 Comments

MDS News SOHO 2026 Meetings / Conferences Video Interviews

What can research funding entities do to help progress in MDS with Timothy Graubert, MD

by SOHO Insider Editors
September 4, 2026
0 Comments

MDS News SOHO 2026 Meetings / Conferences

Study identifies factors that predict response to imetelstat for MDS treatment

by Kerri Fitzgerald
September 4, 2026
0 Comments

keyboard

MDS News SOHO 2026 Meetings / Conferences

Telomere disorders linked to substantial morbidity, clonal hematopoiesis

by Patrick Daly
September 3, 2026
0 Comments

MDS News SOHO 2026 Meetings / Conferences Myelodysplastic Syndromes News

Elritercept demonstrates effective, durable responses across LR-MDS subgroups

by Patrick Daly
September 2, 2026
0 Comments

Young scientists conducting research investigations in a medical laboratory, a researcher in the foreground is using a microscope

MDS News SOHO 2026 Meetings / Conferences Myelodysplastic Syndromes

Ofirnoflast improves transfusion burden, hemoglobin levels in LR-MDS

by Patrick Daly
September 2, 2026
0 Comments

MDS News SOHO 2026 Meetings / Conferences News

Study characterizes excess mortality and survival factors in RS–positive MDS

by Patrick Daly
September 1, 2026
0 Comments

1
2

Top Categories

Cellular Therapy

82

Leukemia

133

Lymphoma

141

Multiple Myeloma

120

Myelodysplastic Syndromes

49

Myeloproliferative Neoplasms

36

POPULAR NEWS

The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.

About

About Us / Editorial Board

Advertising

Contact Us

Support SOHO

Categories

Study characterizes excess mortality and survival factors in RS–positive MDS

Cellular Therapy

Study characterizes excess mortality and survival factors in RS–positive MDS

Leukemia

Study characterizes excess mortality and survival factors in RS–positive MDS

Lymphoma

Study characterizes excess mortality and survival factors in RS–positive MDS

Multiple Myeloma

Study characterizes excess mortality and survival factors in RS–positive MDS

Myelodysplastic Syndromes

Study characterizes excess mortality and survival factors in RS–positive MDS

Myeloproliferative Neoplasms

Subscribe

Recent Posts

Fibrotic low-risk MDS associated with elevated IL-1β and reduced IL-5

Dr. Valeria Santini gives overview of SOHO 2026 MDS session

GGM

Drs. Nastoupil and Garcia-Manero discuss Friday’s plenary session at SOHO 2026

Copyright © 2026 Society of Hematologic Oncology, All rights reserved.